George Washington University
Otolaryngology residency · Washington, DC · George Washington University programs · Program website
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is George Washington University's research in otolaryngology, which the program shares with other departments and affiliated hospitals.
Otolaryngology at George Washington Universityshared by every program there, not this program's own
Institution-level: all otolaryngology publications from George Washington University and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
11
works per year
28th of 57 institutions with otolaryngology residencies
+26.3%
2-year growth
16th of 56 institutions with otolaryngology residencies
19.4%
in top 10% of field (works before 2025)
31st of 40 institutions with otolaryngology residencies
48.4%
cited above world average
29th of 40 institutions with otolaryngology residencies
Works per year · * 2026 so far
Otorhinolaryngology · 50
Otolaryngology research topics at George Washington University
Papers in the window; each links to the list on OpenAlex.
Most cited at George Washington University since 2024
All otolaryngology papers there on OpenAlex
- Impact of neighbor-level disadvantage on survival outcomes in head and neck squamous cell carcinomaWilliam J. Benjamin et al. · Cancer Causes & Control · 2025 · PubMed · cited 2
- Alcohol consumption and upper aerodigestive tract squamous cell carcinoma: evidence from 28 prospective cohortsElmira Ebrahimi et al. · JNCI Journal of the National Cancer Institute · 2025 · PubMed · cited 3
- Phase II trial of neoadjuvant chemotherapy (NAC) docetaxel-cisplatin alone (DC) or with anti-human papillomavirus (HPV) gene therapy PRGN-2009 (DCP) followed by surgery in patients (pts) with newly diagnosed HPV-associated oropharyngeal cancer (HPV-OPC).Charalampos S. Floudas et al. · Journal of Clinical Oncology · 2025 · cited 2
- Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck CancerDan Paul Zandberg et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 29
- Pathologic responses and clinical outcomes with neoadjuvant doublet chemotherapy for newly diagnosed, surgically-resectable p16-positive oropharyngeal cancerAlisha Ria Pershad et al. · Oral Oncology · 2025 · PubMed · cited 3
- Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trialLoren K. Mell et al. · The Lancet Oncology · 2024 · PubMed · cited 70
- Phase Ib Study of the Immunocytokine Simlukafusp Alfa (FAP-IL2v) in Combination with Cetuximab in Patients with Head and Neck Squamous Cell CarcinomaAaron Richard Hansen et al. · Clinical Cancer Research · 2024 · PubMed · cited 9
- Factors Impacting Provider Treatment Decision‐Making in Early Glottic CancerMatthew Shneyderman et al. · The Laryngoscope · 2024 · PubMed · cited 6
- Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiationAlisha Ria Pershad et al. · Cancer Medicine · 2024 · PubMed · cited 2
- Durvalumab in combination with chemoradiotherapy in patients with head and neck squamous cell carcinoma: Results from the Phase 1 CLOVER studyJulie E. Bauman et al. · Head & Neck · 2024 · PubMed · cited 2
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
Badge linking to this page
<a href="https://openprograms.org/programs/george-washington-university-ent"><img src="https://openprograms.org/programs/george-washington-university-ent/badge.svg" alt="George Washington University Otolaryngology residency on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.